These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Molecular diagnosis of hematologic neoplasms]. Lin Y; Ru K Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):612-4. PubMed ID: 26705191 [No Abstract] [Full Text] [Related]
23. Population-based incidence of myeloid malignancies: fifteen years of epidemiological data in the province of Girona, Spain. Osca-Gelis G; Puig-Vives M; Saez M; Gallardo D; Lloveras N; Marcos-Gragera R Haematologica; 2013 Aug; 98(8):e95-7. PubMed ID: 23812933 [No Abstract] [Full Text] [Related]
24. [Introduction to the molecular diagnostic methods of oncohematology]. Király AP; Alpár D; Fésüs V; Marosvári D; Matolcsy A; Bödör C Magy Onkol; 2016 Jun; 60(2):88-98. PubMed ID: 27275635 [TBL] [Abstract][Full Text] [Related]
26. The incidence of co-existing BCR-ABL1 and JAK2 V617F rearrangements: implications for molecular diagnostics. McCarron SL; Haslam K; Crampe M; Langabeer SE Lab Hematol; 2012 Dec; 18(4):20-1. PubMed ID: 23253862 [No Abstract] [Full Text] [Related]
27. Prognostic significance of del(20q) in patients with hematological malignancies. Brezinová J; Zemanová Z; Ransdorfová S; Sindelárová L; Sisková M; Neuwirtová R; Cermák J; Michalová K Cancer Genet Cytogenet; 2005 Jul; 160(2):188-92. PubMed ID: 15993278 [TBL] [Abstract][Full Text] [Related]
28. Molecular genetic methods in the diagnosis of hematologic neoplasms. Sen F; Vega F; Medeiros LJ Semin Diagn Pathol; 2002 May; 19(2):72-93. PubMed ID: 12036283 [TBL] [Abstract][Full Text] [Related]
29. Indications and diagnostic utility of bone marrow examination in different bone marrow disorders in Iran. Mirzai AZ; Hosseini N; Sadeghipour A Lab Hematol; 2009; 15(4):38-44. PubMed ID: 19923104 [TBL] [Abstract][Full Text] [Related]